| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Purpura, Schoenlein-Henoch | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Glomerulonephritis | |||||
| Purpura | |||||
| 3 | More general conditions related to this trial | ||||
| Blood Coagulation Disorders | |||||
| Cardiovascular Diseases | |||||
| Hematologic Diseases | |||||
| Hemorrhagic Disorders | |||||
| Hemostatic Disorders | |||||
| Hypersensitivity | |||||
| Immune Complex Diseases | |||||
| Immune System Diseases | |||||
| Kidney Diseases | |||||
| Nephritis | |||||
| Signs and Symptoms | |||||
| Skin Manifestations | |||||
| Urologic Diseases | |||||
| Vascular Diseases | |||||
| Vasculitis | |||||
| Vasculitis, Hypersensitivity | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Cyclosporine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antifungal Agents | |||||
| Antirheumatic Agents | |||||
| Dermatologic Agents | |||||
| Enzyme Inhibitors | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Oulu University Hospital | |||||
|
